Considerations in boosting COVID-19 vaccine immune responses

Lancet. 2021 Oct 9;398(10308):1377-1380. doi: 10.1016/S0140-6736(21)02046-8. Epub 2021 Sep 14.

¹ Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: philip.krause@fda.hhs.gov.
² Department of Biostatistics, University of Washington, Seattle, WA, USA.
³ Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁴ Department of Biostatistics, University of Florida, Gainesville, FL, USA.
⁵ University of the West Indies, Mona, Jamaica.
⁶ Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
⁷ Universidad Nacional Autónoma de México, DF, Mexico.
⁸ Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
⁹ Centre of Research in Epidemiology and Statistics (CRESS), Université de Paris, Paris, France.
¹⁰ MRC Population Health Research Unit, University of Oxford, Oxford, UK.
¹¹ Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA.
¹² The INCLEN Trust International, New Delhi, India.
¹³ World Health Organization, Geneva, Switzerland.
¹⁴ World Health Organization, Geneva, Switzerland. Electronic address: henaorestropa@who.int.

No abstract available

Publication types